Andrew Cheng Net Worth & Insider Trades

Andrew Cheng - President and CEO, Akero Therapeutics, Inc

As of September 25, 2023

What is Andrew Cheng's Net Worth?

The current estimated net worth of Akero Therapeutics, Inc's President and CEO, Andrew Cheng, is estimated to be about $30.91M . Andrew Cheng owns about 460,998 units of Akero Therapeutics, Inc common stock. In the last 4 years at Akero Therapeutics, Inc, Andrew Cheng has sold an estimated value of $16.33M worth.

What is Andrew Cheng's Past Insider Trading?

Andrew Cheng's largest purchase order was 25,000 units , worth over $159K on September 18, 2023. Andrew Cheng's largest sale order was 60,000 units , worth over $1.65M on September 15, 2022. In total, Andrew Cheng has made about 38 transactions over 4 years of their time at Akero Therapeutics, Inc. Andrew Cheng usually trades in December, with the busiest year in 2023. The most recent transaction was a sale order of 1,682 units , worth over $84.67K on September 25, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Andrew Cheng

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Andrew Cheng's' Mailing Address?

  • Mailing address is 170 Harbor Way, 3rd Floor C/o Akero Therapeutics, Inc. South San Francisco CA 94080 CA

What are Akero Therapeutics, Inc's Past Insider Trades?

Akero Therapeutics, Inc's most recent insider trade came on September 25, 2023 by Andrew Cheng who sold 1,682 units worth $84.67K . In the last 4 years, insiders at Akero Therapeutics, Inc have sold an estimated value of $168.22M and bought an estimated value of $105.14M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Andrew Cheng, President and CEO,  Jonathan Young, Chief Operating Officer,  and Richard William White, Chief Financial Officer .

Akero Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...